MX2022006828A - Formulaciones que comprenden un mineral y/o una vitamina y un polisacarido, composiciones de los mismos y uso de los mismos para complementar dicho mineral y/o vitamina. - Google Patents

Formulaciones que comprenden un mineral y/o una vitamina y un polisacarido, composiciones de los mismos y uso de los mismos para complementar dicho mineral y/o vitamina.

Info

Publication number
MX2022006828A
MX2022006828A MX2022006828A MX2022006828A MX2022006828A MX 2022006828 A MX2022006828 A MX 2022006828A MX 2022006828 A MX2022006828 A MX 2022006828A MX 2022006828 A MX2022006828 A MX 2022006828A MX 2022006828 A MX2022006828 A MX 2022006828A
Authority
MX
Mexico
Prior art keywords
vitamin
mineral
formulations
compositions
supplementing
Prior art date
Application number
MX2022006828A
Other languages
English (en)
Inventor
Andrea Lacorte
Germano Tarantino
Elisa Brilli
Original Assignee
Alesco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco Srl filed Critical Alesco Srl
Publication of MX2022006828A publication Critical patent/MX2022006828A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una formulación en forma sólida a base de un nutriente que comprende: (a) un mineral o una vitamina (b) un fosfolípido, (c) un primer agente seleccionado de (c-i) carragenano y (c-ii) goma acacia, y, opcionalmente, (d) un sucrester y/o (e) un almidón de origen vegetal. Además, la presente invención se refiere a una composición que comprende al menos una de dichas formulaciones y el uso del mismo en el tratamiento de una deficiencia de dicho mineral y/o vitamina. Por último, la presente invención se refiere a un proceso para la preparación de dichas formulaciones o composiciones.
MX2022006828A 2019-12-04 2020-12-04 Formulaciones que comprenden un mineral y/o una vitamina y un polisacarido, composiciones de los mismos y uso de los mismos para complementar dicho mineral y/o vitamina. MX2022006828A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102019000023016A IT201900023016A1 (it) 2019-12-04 2019-12-04 Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale
PCT/IB2020/061521 WO2021111404A1 (en) 2019-12-04 2020-12-04 Formulations comprising a mineral and/or a vitamin and a polysaccharide, compositions thereof and use thereof in supplementing said mineral and/or vitamin

Publications (1)

Publication Number Publication Date
MX2022006828A true MX2022006828A (es) 2022-09-23

Family

ID=70154909

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006828A MX2022006828A (es) 2019-12-04 2020-12-04 Formulaciones que comprenden un mineral y/o una vitamina y un polisacarido, composiciones de los mismos y uso de los mismos para complementar dicho mineral y/o vitamina.

Country Status (14)

Country Link
US (1) US20230019690A1 (es)
EP (1) EP4069194A1 (es)
JP (1) JP2023505246A (es)
KR (1) KR20220122654A (es)
CN (1) CN115052582A (es)
AU (1) AU2020396464A1 (es)
BR (1) BR112022010834A2 (es)
CA (1) CA3163312A1 (es)
EC (1) ECSP22047989A (es)
IL (1) IL293452A (es)
IT (1) IT201900023016A1 (es)
JO (1) JOP20220136A1 (es)
MX (1) MX2022006828A (es)
WO (1) WO2021111404A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200010583A1 (it) * 2022-05-23 2023-11-23 Neilos S R L “Composizione nutraceutica o farmaceutica per l’infertilità maschile”

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1077342A (zh) * 1992-04-17 1993-10-20 金昌松 米、面类强化营养粉的配制方法
US6541048B2 (en) * 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
CN101455401B (zh) * 2009-01-16 2012-01-18 北京天维新探生物科技有限公司 复合型多功能食品营养强化剂
CN102077944B (zh) * 2010-09-20 2013-08-21 王强 一种前列腺患者专用的海洋特膳食品
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.

Also Published As

Publication number Publication date
BR112022010834A2 (pt) 2022-08-23
WO2021111404A1 (en) 2021-06-10
CN115052582A (zh) 2022-09-13
KR20220122654A (ko) 2022-09-02
CA3163312A1 (en) 2021-06-10
EP4069194A1 (en) 2022-10-12
IT201900023016A1 (it) 2021-06-04
JOP20220136A1 (ar) 2023-01-30
AU2020396464A1 (en) 2022-06-16
ECSP22047989A (es) 2022-08-31
US20230019690A1 (en) 2023-01-19
IL293452A (en) 2022-07-01
JP2023505246A (ja) 2023-02-08

Similar Documents

Publication Publication Date Title
UA100671C2 (ru) Применение алкилэтерсульфатов как добавок с низкой пенообразующей способностью для усиления действия растворимых или частично расстворимых в воде агрохимикатов, композиции на них основе и способ борьбы с нежелательным ростом растений
MX2021000020A (es) Composicion y metodo para tratar el dolor.
DK1841332T4 (da) Fortykningsmiddelsammensætning til dysfagipatienter
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MX2021013581A (es) Composiciones de nanoemulsiones que comprenden ingredientes biologicamente activos.
IL186104A (en) Phosphoramidate History of Nucleoside Compounds
NZ742943A (en) Compositions comprising a biological control agent and a fungicide from the group consisting of inhibitors of the respiratory chain at complex i or ii
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
MX2012012837A (es) Composiciones farmaceuticas y metodos para su elaboracion.
MX2009013295A (es) Estuche y metodo para aplicaciones de tratamiento para el cabello.
TW200833351A (en) New cosmetic and/or pharmaceutical compositions and their applications
MX2017006942A (es) Nuevos derivados de ester fosforamidato 3'-desoxiadenosina de 2' y/o 5' aminoacido como compuestos anti-cancer.
MX2011007288A (es) Trozos en composicones alimenticias gelatinosas.
MX2022013066A (es) Formulacion estable.
MX2023006677A (es) Composiciones para tratar la degeneracion macular seca relacionada con la edad (dme).
JOP20220136A1 (ar) صياغات تشتمل على معدن و/أو فيتامين وبولي سكاريد، تركيبات منها واستخدامها في المعدن و/أو الفيتامين المُكمل المذكور
WO2020146700A8 (en) Lipid nanoparticles
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
MX2017000454A (es) Composiciones bucales antisarro.
MX2022002541A (es) Agente bioestimulante para tratar plantas y/o semillas de plantas.
MX2020007779A (es) Composiciones y métodos para tratar la cavidad bucal.
MX2015009348A (es) Composiciones hemostaticas.
SG10201807034XA (en) A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease
BRPI0416747A (pt) métodos e formulações para o tratamento de condições médicas relacionadas à dihidrotesterona elevada
AU2018279977A1 (en) Natural and organic binder compositions for oral solid dosage forms